Cetera Investment Advisers
JAZZ icon

Cetera Investment Advisers’s Jazz Pharmaceuticals JAZZ Stock Holding History

Cetera Investment Advisers’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Buy
6,244
+207
+3% +$45.3K ﹤0.01% 2660
2026
Q1 		$1.14M Sell
6,037
-39
-0.6% -$6.82K ﹤0.01% 2794
2025
Q4 		$1.03M Sell
6,076
-2,534
-29% -$388K ﹤0.01% 2788
2025
Q3 		$1.13M Buy
8,610
+1,504
+21% +$180K ﹤0.01% 2670
2025
Q2 		$754K Sell
7,106
-3,430
-33% -$373K ﹤0.01% 2632
2025
Q1 		$1.31M Buy
10,536
+444
+4% +$57.9K ﹤0.01% 2054
2024
Q4 		$1.24M Buy
+10,092
New +$1.19M ﹤0.01% 2017
2024
Q2 		– Sell
-2,460
Closed -$296K – 3803
2024
Q1 		$296K Buy
+2,460
New +$301K ﹤0.01% 3053

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Cetera Investment Advisers's JAZZ Position: Q2 2026 in Review

Cetera Investment Advisers increased its Jazz Pharmaceuticals (JAZZ) stake by 3.4% in Q2 2026, buying an estimated $45.3K and bringing the position to 6,244 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2660.

Cetera Investment Advisers first reported a position in JAZZ in Q1 2024 and has held it in 8 quarters since. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Cetera Investment Advisers held 6,244 shares of Jazz Pharmaceuticals worth $1.5M as of Q2 2026.
  • Cetera Investment Advisers bought 207 Jazz Pharmaceuticals shares in Q2 2026, an estimated $45.3K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2660 holding.
  • Cetera Investment Advisers first reported a position in Jazz Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.